2. PROTAC Vitamin D Related/Nuclear Receptor Apoptosis
  3. PROTACs Estrogen Receptor/ERR Apoptosis
  4. PROTAC ERα Degrader-12

PROTAC ERα Degrader-12 is a potent and selective Erα PROTAC degrader. PROTAC ERα Degrader-12 has antiproliferative effects in multiple breast cancer cell lines with wild-type or mutant ERα. PROTAC ERα Degrader-12 can halt the cell cycle and induce cell apoptosis. PROTAC ERα Degrader-12 exhibits excellent antitumor and ERα degradation activity. PROTAC ERα Degrader-12 can be used for research on breast cancer. (Pink: ER ligand-11 (HY-174475); Blue: VHL ligand (HY-112078); Black: Linker (HY-W088749); VHL ligand + Linker ( HY-W998310)).

For research use only. We do not sell to patients.

PROTAC ERα Degrader-12 Chemical Structure

PROTAC ERα Degrader-12 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

PROTAC ERα Degrader-12 Related Antibodies

Top Publications Citing Use of Products

View All PROTACs Isoform Specific Products:

View All Isoforms
von Hippel-Lindau (VHL) Cereblon MDM2 cIAP1

View All Estrogen Receptor/ERR Isoform Specific Products:

View All Isoforms
Estrogen receptor ERα ERβ ERRα ERRβ ERRγ

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

PROTAC ERα Degrader-12 is a potent and selective Erα PROTAC degrader. PROTAC ERα Degrader-12 has antiproliferative effects in multiple breast cancer cell lines with wild-type or mutant ERα. PROTAC ERα Degrader-12 can halt the cell cycle and induce cell apoptosis. PROTAC ERα Degrader-12 exhibits excellent antitumor and ERα degradation activity. PROTAC ERα Degrader-12 can be used for research on breast cancer. (Pink: ER ligand-11 (HY-174475); Blue: VHL ligand (HY-112078); Black: Linker (HY-W088749); VHL ligand + Linker ( HY-W998310))[1].

In Vitro

PROTAC ERα Degrader-12 (Compound CP03) (0.1-10 μM, 24 h) demonstrates significant ERα degradation activity in MCF-7 cells with DC50 value of 1.02 μM[1].
PROTAC ERα Degrader-12 (0.01-100 μM, 24 h) exhibits potent anticancer activity in MCF-7 cells (IC50 = 0.17 μM)[1].
PROTAC ERα Degrader-12 exhibits remarkable stability in human liver microsomes and plasma with the level of plasma protein binding of 97.8%[1].
PROTAC ERα Degrader-12 (1-5 μM, 48 h) halts the cell cycle progression in the G1 phase and induces substantial cellular death and damage in MCF-7[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

PROTAC ERα Degrader-12 Related Antibodies

Western Blot Analysis[1]

Cell Line: MCF-7, MDA-MB-321, MCF-7Y537S, MCF-7D538G, MCF-7EGFR, and LCC-2 cell lines
Concentration: 0.1, 0.2, 1, 2, 5, 10 μM
Incubation Time: 24 h
Result: Effectively induced ERα degradation in a dose-dependent manner in MCF-7 cells.
Efficiently reduced the ErαMUT levels in both the MCF-7Y537S and MCF-7D538G cell lines with DC50 values of 0.83 and 0.55 μM, respectively.
Showed high degradation potency for ERα in MCF-7EGFR and LCC-2 cell lines, with DC50 values of 0.13 and 1.40 μM, respectively.

Western Blot Analysis[1]

Cell Line: MCF-7
Concentration: 2 μM
Incubation Time: 24 h
Result: Was markedly suppressed in the presence of CoA-1 or CoA-2.

Cell Viability Assay[1]

Cell Line: MCF-7, MDA-MB-321, MCF-7Y537S, MCF-7D538G, MCF-7EGFR, and LCC-2 cell lines
Concentration: 0.01, 0.1, 1, 10, 100 μM
Incubation Time: 24 h
Result: Had no notable inhibitory influence on cell growth in the ER-negative cell line MDA-MB-231 at concentrations exceeding 100 μM.
Exhibited excellent antiproliferative activity in MCF-7 Y537S , MCF-7D538G , and MCF-7EGFR, with IC50 values that were 10.3-, 19.4-, and 58.0-fold higher than those of Ful, respectively.
Displayed enhanced antiproliferative efficacy against tamoxifen-resistant LCC-2 cells, with an IC50 value that was 8.04-fold higher than that of Fulvestrant (HY-13636).

RT-PCR[1]

Cell Line: MCF-7
Concentration: 0.1, 1 μM
Incubation Time: 24 h
Result: Had no discernible impact on the mRNA of ERα expression.

Apoptosis Analysis[1]

Cell Line: MCF-7, MDA-MB-321, MCF-7Y537S, MCF-7D538G, MCF-7EGFR, and LCC-2 cell lines
Concentration: 1, 5 μM
Incubation Time: 48 h
Result: Induced substantial cellular death and damage in a concentration-dependent manner.
Effectively halted the cell cycle progression in the G1 phase.
In Vivo

PROTAC ERα Degrader-12 (Compound CP03) (1-4 mg/kg, i.p., every other day for 26 or 33 days) exhibits significant tumor-inhibitory effects in mice MCF-7 and LCC-2 tumor xenograft models[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MCF-7 and LCC-2 tumor xenograft models, Female BALB/c nude mice (15-18 g, 5 weeks old) [1]
Dosage: 1, 2, 4 mg/kg
Administration: Intraperitoneal injection (i.p.), every other day, for 26 or 33 days.
Result: Showed significant tumor growth inhibitory activity at 2 mg/kg.
Had no significant host toxicity as monitored by changes in the body weight.
Almost completely inhibited tumor growth on day 33 at a dose of 2 or 4 mg/kg.
Effectively induced significant degradation of ERα with 2 mg/kg.
Molecular Weight

930.34

Formula

C53H83N7O5S
SMILES

CC(C)([C@H](NC(CCCCC(NCC1=C(C(CN)=C(C(CN)=C1CCCCC)CCCCC)CCCCC)=O)=O)C(N2C[C@H](O)C[C@H]2C(N[C@H](C3=CC=C(C=C3)C4=C(C)N=CS4)C)=O)=O)C
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

PROTAC ERα Degrader-12 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

PROTAC ERα Degrader-12PROTAC ERα Degrader12PROTAC ERα Degrader 12PROTACsEstrogen Receptor/ERRApoptosisBreast cancerErαPROTACMCF-7LCC-2Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
PROTAC ERα Degrader-12
Cat. No.:
HY-174453
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.